小冠状动脉病变的支架应用(摘要)
作者：厉锦华 王彬尧 刘建平 张清 何奔 黄定九
单位：上海市，上海第二医科大学附属仁济医院 心内科(200001)
关键词：
中国循环杂志99zk56 目的：文献报道支架治疗经皮冠状动脉腔内成形术(PTCA)术中急性闭塞和防治>2.5 mm直径小冠状动脉再狭窄很有益处。我们评价支架应用于小冠状动脉病变的临床效果。
方法：18例(男性16例)患者，安装24个支架在直径<2.78 mm冠状动脉中。门诊随访所有患者，对有心绞痛复发者，重复冠状动脉造影。
结果：24个支架(NIR 16个，Palmaz-Schtz 2个，AVE 6个)置入18位冠心病患者(其中一根德管病变者13人，二根血管3人，三根血管2人)，支架安装指征为：PTCA术中发生夹层或效果欠佳者。置入1个支架者14例，2个支架者2例，3个支架者2例。15个支架放在左前降支(LAD)4个放在回旋支(LCX)，5个支架放在右冠状动脉(RCA)。支架长度是9 mm,5个；16 mm,15个；25 mm,4个。术后院内无死亡，无冠状动脉旁路移植(CABG)，无支架阻塞，心肌梗塞1例。4～28个月门诊随访，1例猝死，1例心绞痛，造影发现再狭窄经PTCA后缓解，无心肌梗塞、CABG。
, http://www.100md.com
结论：尽管有3例患者发生心脏并发症，但小冠状动脉病变的支架应用短期、长期临床效果是可以接受的。
Stent in Small Vessel (Abstract)
Department of Cardiology, Ren Ji Hospital of Shanghai Second Medical University, Shanghai (200001)
Li Jinhua, Wang Binyao, Liu Jianping, et al.
Objective: Intracoronary stenting has been demonstrated to be useful in the treatment of acute closure during percutaneous transluminal coronary angioplasty (PTCA) and as a tool to preventrestenosis in vessels over 2.5 mm in diameter. We assessed the clinical efficacy of the stents in the management of small vessel disease.
, 百拇医药
Methods: Eighteen pts (male 16) received 24 stents in vessels less than 2.78 mm in diameter. Clinical follow-up was conducted for all pts and repeated angiography was only performed in pts with recurrence of symptoms.
Results: Twenty-four stents (NIR 16, Palmaz-Shatz 2, AVE 6) were implanted in 18 pts with coronary heart disease affecting one (13), two (3) or three (2) vessels. Indications for stenting were suboptimal results or dissection after PTCA. 14 pts received one stent. 2 pts received two stents. 2 pts received three stents. Target sites were LAD (15 stents), LCX (4 stents), RCA (5 stents). The lenghts of the stents were 9 mm (5), 16 mm (15), 25 mm (4). Incidence of in-hospital complications were death 0, myocardiac infarction 1 pt, in-stent occlusion 0, and CABG 0. During 4～28 months′ clinical follow-up on 17 pts, one patient died, myocardial infarction occured in 0. Symptomatic restenosis in one pt (relieved by PTCA), CABG in 0.
Conclusion: In spite of three pts having cardiac events, short-adn long-term clinical outcome of stenting in small vessels in this study is acceptable., 百拇医药
单位：上海市，上海第二医科大学附属仁济医院 心内科(200001)
关键词：
中国循环杂志99zk56 目的：文献报道支架治疗经皮冠状动脉腔内成形术(PTCA)术中急性闭塞和防治>2.5 mm直径小冠状动脉再狭窄很有益处。我们评价支架应用于小冠状动脉病变的临床效果。
方法：18例(男性16例)患者，安装24个支架在直径<2.78 mm冠状动脉中。门诊随访所有患者，对有心绞痛复发者，重复冠状动脉造影。
结果：24个支架(NIR 16个，Palmaz-Schtz 2个，AVE 6个)置入18位冠心病患者(其中一根德管病变者13人，二根血管3人，三根血管2人)，支架安装指征为：PTCA术中发生夹层或效果欠佳者。置入1个支架者14例，2个支架者2例，3个支架者2例。15个支架放在左前降支(LAD)4个放在回旋支(LCX)，5个支架放在右冠状动脉(RCA)。支架长度是9 mm,5个；16 mm,15个；25 mm,4个。术后院内无死亡，无冠状动脉旁路移植(CABG)，无支架阻塞，心肌梗塞1例。4～28个月门诊随访，1例猝死，1例心绞痛，造影发现再狭窄经PTCA后缓解，无心肌梗塞、CABG。
, http://www.100md.com
结论：尽管有3例患者发生心脏并发症，但小冠状动脉病变的支架应用短期、长期临床效果是可以接受的。
Stent in Small Vessel (Abstract)
Department of Cardiology, Ren Ji Hospital of Shanghai Second Medical University, Shanghai (200001)
Li Jinhua, Wang Binyao, Liu Jianping, et al.
Objective: Intracoronary stenting has been demonstrated to be useful in the treatment of acute closure during percutaneous transluminal coronary angioplasty (PTCA) and as a tool to preventrestenosis in vessels over 2.5 mm in diameter. We assessed the clinical efficacy of the stents in the management of small vessel disease.
, 百拇医药
Methods: Eighteen pts (male 16) received 24 stents in vessels less than 2.78 mm in diameter. Clinical follow-up was conducted for all pts and repeated angiography was only performed in pts with recurrence of symptoms.
Results: Twenty-four stents (NIR 16, Palmaz-Shatz 2, AVE 6) were implanted in 18 pts with coronary heart disease affecting one (13), two (3) or three (2) vessels. Indications for stenting were suboptimal results or dissection after PTCA. 14 pts received one stent. 2 pts received two stents. 2 pts received three stents. Target sites were LAD (15 stents), LCX (4 stents), RCA (5 stents). The lenghts of the stents were 9 mm (5), 16 mm (15), 25 mm (4). Incidence of in-hospital complications were death 0, myocardiac infarction 1 pt, in-stent occlusion 0, and CABG 0. During 4～28 months′ clinical follow-up on 17 pts, one patient died, myocardial infarction occured in 0. Symptomatic restenosis in one pt (relieved by PTCA), CABG in 0.
Conclusion: In spite of three pts having cardiac events, short-adn long-term clinical outcome of stenting in small vessels in this study is acceptable., 百拇医药